Biotricity is trading at $0.06, up 10.00%, with healthcare up 2.12% in the supplied market context, offering sector-level support, but no direct company catalyst is confirmed. - Biotricity’s newsroom lists no company-specific announcement for October 21, 2026. - Current volume was not provided, so trading activity cannot be assessed.